Modify CT Protocol: CDSCO Panel Tells GSK on Respiratory Syncytial Virus(RSV) Vaccine Dr. Divya Colin24 March 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial protocol presented by the drug major GSK for the Respiratory Syncytial Virus (RSV) vaccine...
CDSCO Panel grants GSK's Updated Prescribing Information for Antibiotic FDC of Amoxicillin, Clavulanic acid Dr. Divya Colin21 March 2024 5:45 PM ISTNew Delhi: The drug major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Pfizer divests USD 3.5 billion stake in Haleon Ruchika Sharma21 March 2024 2:10 PM ISTSensodyne-marker Haleon has said that Pfizer, its top shareholder, divested approximately a $3.5 billion stake in the consumer healthcare firm,...
WHO issues warning for growing resistance to HIV drug of GSK Roshni Dhar11 March 2024 5:58 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
Health Bulletin 11/ March/ 2024 Roshni Dhar11 March 2024 4:58 PM ISTHere are the top health news for the day:NEET UG 2024 registration deadline extendedThe deadline for NEET 2024 application submissions has been...
WHO warns of growing resistance to GSK HIV drug Ruchika Sharma6 March 2024 12:30 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
GSK CEO Emma Walmsley total remuneration rises 51 percent to USD 16 million in 2023 Ruchika Sharma4 March 2024 10:00 AM ISTLondon: GSK CEO Emma Walmsley's total remuneration rose 51 per cent to 12.7 million pounds ($16 million) in 2023, thanks to a big jump in...
Heartburn drug: GSK settles another lawsuit on Zantac in California Ruchika Sharma3 March 2024 2:00 PM ISTThe USFDA in 2020 pulled all brands named Zantac and generic versions of the drug off the market, triggering a wave of lawsuits.
Gepotidacin potential novel oral treatment option for uncomplicated gonorrhoea: EAGLE-1 phase III trial shows Medha Baranwal2 March 2024 2:15 AM ISTUK: Gepotidacin, a first-in-class triazaacenaphthylene antibiotic, demonstrated non-inferiority to the current standard-of-care gonorrhoea treatment...
GSK posts positive headline results from phase III trial for Gepotidacin in uncomplicated urogenital gonorrhoea Ruchika Sharma27 Feb 2024 2:30 PM ISTGSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, a potential first-in-class oral antibiotic...
Indian Pharmaceutical Market soars with 9.5% growth in January 2024: Pharmarack Report Farhat Nasim20 Feb 2024 5:56 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) exhibited a robust growth of 9.5% in terms of value and 2.07% in units, reaching a total value of...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
